Expression of p27 and p16 and their clinical significance in gastric cancer
- PDF / 1,254,723 Bytes
- 10 Pages / 595.276 x 790.866 pts Page_size
- 66 Downloads / 189 Views
RESEARCH ARTICLE
Expression of p27 and p16 and their clinical significance in gastric cancer S. Kumari1 · P. Kumar2 · M. Kumar3 · S. Singh4 · G. Narayan1 Received: 29 April 2020 / Accepted: 10 August 2020 © Federación de Sociedades Españolas de Oncología (FESEO) 2020
Abstract Background Deregulated expression of cell cycle regulators p27 and p16 is associated with cancer progression. p27kip1 and p16INKa are a cyclin dependent kinase inhibitor whose major target is the cyclinE/CDK2 and cyclinD/CDK4/6 complex, respectively, that governs cell cycle transition from late G1 to S phase. Methods We recruited biopsies of a total of 84 subjects including 72 primary tumor biopsies from histopathologically proven gastric carcinoma, 8 adjacent controls and 12 independent controls. We used gastric cancer cell line, AGS, for validation of our data. Expression profiling at transcript level was done by semi-quantitative RT-PCR and at proteome level by immunohistochemistry and immunofluorescence. Receiver operator characteristics analysis was done for determining the diagnostic utility of p27 and p16 with respect to the sensitivity and specificity. Results We demonstrate that p27 and p16 are frequently over expressed in early stages of gastric carcinoma. Our semiquantitative data show a significant upregulation of p27 (Mean ± SEM, 0.4771 ± 0.0895; p = 0.0001) and p16 (Mean ± SEM, 0.4676 ± 0.04305; p = 0.0001) at mRNA level. Concordant to semi-quantitative data, immunohistochemistry data also showed a significant upregulation of p27 (Mean ± SEM, 196.4 ± 10.84; p 60 (21) Intestinal (38) Diffuse (34) Proximal (8) Middle (13) Proximal (8) Distal (51) Middle (13) Distal (51) Differentiated (35) Undifferentiated (37) Serosal –ve (19) Serosal + ve (53) Venous –ve (66) Venous + ve (6) Lymphatic –ve (53) Lymphatic + ve (19) Lymph node –ve (10) Lymph node + ve (62) Peretoneal –ve (56) Peretoneal + ve (16) Ascitis –ve (50) Ascitis + ve (22) Liver –ve (64) Liver + ve (8) I + II (16) III + IV (56)
Frequency of p27 and p16 up regulated tumors at mRNA and protein level p27 mRNA
p27 protein
p21 mRNA
p16 protein
% (p value)
% (p value)
% (p value)
% (p value)
55.5 (
Data Loading...
